Foundation year: 1957

Valid certificates:

LRP sertifikāts Nr. ZVA/LV/2013/012H Bioloģiski aktīvu savienojumu analīzes laboratorijai

Summary:
an independent public research institute since 1957 performing research in organic and medicinal chemistry, pharmacology, bioanalytics and biophysics
one of the leading research institutions in Latvia, 236 FTE employees, including 189 PhD and MSc
over 60 years experience in the drug design and technology development
an inventor and co-inventor of 18 original approved drugs and more than 70 original preparation methods of known medicines
located in Riga and possesses about 5000m2 of equipped laboratory space
Strengths:
teams of experienced organic chemists capable to solve challenging synthetic tasks
strong analytical chemistry support and experience in application of advanced structure assignment methods (multidimensional NMR, X-ray analysis etc.)
wide range of established in vivo, ex vivo and in vitro pharmacology assays
efficient teamwork with pharmacologists, molecular modeling professionals and other experts for higher success rate

Main markets

  1. 1. Germany
  2. 2. Sweden
  3. 3. Switzerland
  4. 4. United Kingdom
  5. 5. United States

Target Markets

  1. 1. Germany
  2. 2. Sweden
  3. 3. Switzerland
  4. 4. United Kingdom
  5. 5. United States

In which areas are looking for cooperation

  • Education and scientific research

Products

Preclinical drug discovery

LIOS executes a complimentary set of drug discovery and development tasks which includes synthetic hit-to-lead and lead-to-CD programs, compound design, biological activity determination and ADMET profiling. The drug discovery tasks can also be integrated with research activities performed by collaboration partners.

Process chemistry of APIs

LIOS performs route scouting for the manufacturing of original and generic APIs. This includes the design, development and optimization of synthetic and analytical protocols according to the manufacturing requirements. The selected routes are validated in kilo-scale laboratory of LIOS .

Turnover in the last 5 years

Data are not able

Data are not able

Empty chart placeholder

Number of employees in total and after education in the last 5 years

Data are not able

Data are not able

Empty chart placeholder

In which areas are looking for cooperation

  • Education and scientific research

Export volume over the last 5 years

Millions EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

2016 2017 2018 2019 2020
2670232 3683892 n/a n/a n/a

Main markets

  1. 1. Germany
  2. 2. Sweden
  3. 3. Switzerland
  4. 4. United Kingdom
  5. 5. United States

Target Markets

  1. 1. Germany
  2. 2. Sweden
  3. 3. Switzerland
  4. 4. United Kingdom
  5. 5. United States

Investing in R&D

Data are not able

Data are not able

Empty chart placeholder

ATVASINĀTA PUBLISKA PERSONA LATVIJAS ORGANISKĀS SINTĒZES INSTITŪTS

Description about enterprise:

Summary:
an independent public research institute since 1957 performing research in organic and medicinal chemistry, pharmacology, bioanalytics and biophysics
one of the leading research institutions in Latvia, 236 FTE employees, including 189 PhD and MSc
over 60 years experience in the drug design and technology development
an inventor and co-inventor of 18 original approved drugs and more than 70 original preparation methods of known medicines
located in Riga and possesses about 5000m2 of equipped laboratory space
Strengths:
teams of experienced organic chemists capable to solve challenging synthetic tasks
strong analytical chemistry support and experience in application of advanced structure assignment methods (multidimensional NMR, X-ray analysis etc.)
wide range of established in vivo, ex vivo and in vitro pharmacology assays
efficient teamwork with pharmacologists, molecular modeling professionals and other experts for higher success rate

Valid certificates:

LRP sertifikāts Nr. ZVA/LV/2013/012H Bioloģiski aktīvu savienojumu analīzes laboratorijai

Products

Preclinical drug discovery

LIOS executes a complimentary set of drug discovery and development tasks which includes synthetic hit-to-lead and lead-to-CD programs, compound design, biological activity determination and ADMET profiling. The drug discovery tasks can also be integrated with research activities performed by collaboration partners.

Process chemistry of APIs

LIOS performs route scouting for the manufacturing of original and generic APIs. This includes the design, development and optimization of synthetic and analytical protocols according to the manufacturing requirements. The selected routes are validated in kilo-scale laboratory of LIOS .